DELIVER II Registry - DELIVER II Registry

Description:

The goal of the DELIVER II registry trial was to identify factors that lead to an increased risk of target lesion revascularization (TLR) in patients with complex coronary lesions implanted with the paclitaxel nonpolymeric ACHIEVE stent.